An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator.
Cardiac implantable electronic device
Lead extraction
Severe adverse event
Taurolidine
Twiddler’s syndrome
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
15
01
2024
accepted:
10
07
2024
medline:
23
7
2024
pubmed:
23
7
2024
entrez:
22
7
2024
Statut:
epublish
Résumé
Cardiac implantable electronic device (CIED) complications present significant challenges in clinical practice, especially in elderly patients with multiple comorbidities. Common adverse events include infection, lead malfunction, and device migration. Twiddler's Syndrome, a rare but serious CIED complication characterised by patient manipulation causing lead displacement and device malfunction, is often underreported. The literature consists mainly of case reports and small series, providing limited guidance on prevention and management. As CIEDs are critical for managing cardiac arrhythmias and heart failure, understanding and addressing Twiddler's Syndrome is essential. This case report aims to contribute to the literature by detailing a case of Twiddler's Syndrome, emphasising the importance of a multidisciplinary approach for optimal management. A 59-year-old male presented with discomfort around his implantable cardioverter defibrillator (ICD) site and the sternal area over the past two days. He denied pain, dyspnoea, or dizziness. Clinical examination revealed a normal heart rhythm and no peripheral pulse deficit. Ultrasound revealed a reduced left ventricular ejection fraction. The atrial lead was not visible, and the shock coil was misplaced. ICD interrogation showed inappropriate shocks due to sensing artifacts and exit block in both leads, with no arrhythmias detected. An X-ray confirmed lead dislodgement and significant entanglement in the pocket. The patient was diagnosed with Twiddler's Syndrome and scheduled for surgical revision. Dilated cardiomyopathy (DCM), characterised by left ventricular dilatation and dysfunction, accounts for a significant proportion of systolic heart failure cases. Despite advancements in heart failure management, DCM patients remain at high risk for sudden cardiac death (SCD), making ICD implantation crucial. However, CIED placement carries risks of complications, including Twiddler's Syndrome. This condition can lead to lead dislodgement and device malfunction, resulting in inappropriate shocks and potential patient harm. In this case, a single-session extraction and re-implantation were successfully performed using a multidisciplinary approach, emphasising the importance of comprehensive management strategies to address such complications effectively. Regular follow-up showed no adverse events, highlighting the procedure's success and the potential benefits of using advanced antimicrobial adjuncts to prevent infections. This case underscores the need for awareness and standardised protocols for managing Twiddler's Syndrome to improve patient outcomes in the growing population of CIED recipients.
Identifiants
pubmed: 39039491
doi: 10.1186/s12872-024-04038-z
pii: 10.1186/s12872-024-04038-z
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
380Informations de copyright
© 2024. The Author(s).
Références
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.
doi: 10.1056/NEJMoa043399
pubmed: 15659722
Zeitler EP, Al-Khatib SM, Friedman DJ, et al. Predicting appropriate shocks in patients with heart failure: patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol. 2017;28:1345–51.
doi: 10.1111/jce.13307
pubmed: 28744959
pmcid: 5693305
Køber L, Thune JJ, Nielsen JC, et al. Defibrillator Implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–30.
doi: 10.1056/NEJMoa1608029
pubmed: 27571011
Kipp R, Hsu JC, Freeman J, Curtis J, Bao H, Hoffmayer KS. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: a report from the National Cardiovascular Data Registry. Heart Rhythm. 2018;15:847–54.
doi: 10.1016/j.hrthm.2017.09.043
pubmed: 28987459
Blomstrom-Lundqvist C, Traykov V, Erba PA et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020.
Gomez JO, Doukky R, Pietrasik G, Wigant RR, Mungee S, Baman TS. Prevalence and predictors of Twiddler’s syndrome. Pacing Clin Electrophysiol. 2023;46:454–8.
doi: 10.1111/pace.14655
pubmed: 36585766
Yi-Wen Liao B, Lever N, Martin A, Unwrapped. An unexpected association with the absorbable antibacterial envelope. HeartRhythm Case Rep. 2023;9:34–7.
doi: 10.1016/j.hrcr.2022.10.008
pubmed: 36685692
Osoro M, Lorson W, Hirsh JB, Mahlow WJ. Use of an antimicrobial pouch/envelope in the treatment of Twiddler’s syndrome. Pacing Clin Electrophysiol. 2018;41:136–42.
doi: 10.1111/pace.13259
pubmed: 29266324
Casorelli E, Pescatori I, Ruocco G, Bonnemeier H, Assadian O, Bui F. [Pacemaker infection in fragile patients]. Herzschrittmacherther Elektrophysiol. 2023.
Giaccardi M, Baldauf B, Lau EW, Borov S, Bonnemeier H. Salvage of Cardiac Implantable Electronic device Pocket infection with skin Erosion in Frail 92-Year-old. J Cardiovasc Dev Disease. 2022;9:81.
doi: 10.3390/jcdd9030081
Giudice M, Catuzzo B, Berlier N, et al. Use of Taurolidine in a patient with a Cardiac Implantable Electronic device protrusion. JACC: Case Rep. 2023;14:101835.
pubmed: 37152697
Borov S, Baldauf B, Lau EW, Bonnemeier H. Salvage of infected cardiac implantable electronic device with taurolidine—a case report. Cardiothorac Surgeon. 2022;30:7.
doi: 10.1186/s43057-022-00068-5
Timperley J, Leeson P, Mitchell ARJ, Betts T. Pacemakers and ICDs: Oxford University Press; 2018.
Baddour LM, Esquer Garrigos Z, Rizwan Sohail M, et al. Update on Cardiovascular Implantable Electronic device infections and their Prevention, diagnosis, and Management: A Scientific Statement from the American Heart Association: endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation. 2024;149:e201–16.
doi: 10.1161/CIR.0000000000001187
pubmed: 38047353
Tascini C, Giuliano S, Attanasio V, et al. Safety and Efficacy of a single Procedure of extraction and reimplantation of infected Cardiovascular Implantable Electronic device (CIED) in comparison with deferral timing: an Observational Retrospective Multicentric Study. Antibiotics. 2023;12:1001.
doi: 10.3390/antibiotics12061001
pubmed: 37370320
pmcid: 10295375
Borov S, Baldauf B, Henke J et al. Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection. Europace. 2023;25.